Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
86.2M
-
Number of holders
-
90
-
Total 13F shares, excl. options
-
39.1M
-
Shares change
-
+222K
-
Total reported value, excl. options
-
$140M
-
Value change
-
+$645K
-
Put/Call ratio
-
2.59
-
Number of buys
-
36
-
Number of sells
-
-42
-
Price
-
$3.58
Significant Holders of Strata Critical Medical, Inc. - Common Stock, $0.0001 par value per share (SRTA) as of Q4 2022
110 filings reported holding SRTA - Strata Critical Medical, Inc. - Common Stock, $0.0001 par value per share as of Q4 2022.
Strata Critical Medical, Inc. - Common Stock, $0.0001 par value per share (SRTA) has 90 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 39.1M shares
of 86.2M outstanding shares and own 45.32% of the company stock.
Largest 10 shareholders include HG Vora Capital Management, LLC (7.88M shares), ARK Investment Management LLC (7.02M shares), Sumitomo Mitsui Trust Holdings, Inc. (4.84M shares), Nikko Asset Management Americas, Inc. (4.84M shares), BlackRock Inc. (3.7M shares), VANGUARD GROUP INC (2.81M shares), STATE STREET CORP (1.21M shares), GEODE CAPITAL MANAGEMENT, LLC (990K shares), ETF MANAGERS GROUP, LLC (789K shares), and Brandywine Global Investment Management, LLC (528K shares).
This table shows the top 90 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.